Cargando…
Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
INTRODUCTION: To simplify the medical treatment of glaucoma for patients on multiple drops by introducing brinzolamide/brimonidine tartrate fixed combination (BBFC) ophthalmic suspension 1%/0.2% (SIMBRINZA(®); Alcon Laboratories, Inc., Fort Worth, TX, USA) to the drop regimen and to establish its ef...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258589/ https://www.ncbi.nlm.nih.gov/pubmed/30367363 http://dx.doi.org/10.1007/s40123-018-0150-x |